$5.99 Shipping

on US order over $75*

Shopping Cart - $0.00

You have no items in your shopping cart.

Return to Previous Page

TIHKAL: A Continuation - Alexander and Ann Shulgin

$24.50
SKU: bki-9780963009692

Product Dimensions: 804 pages; paperback

Availability: In stock

Quick Overview:

This is the second book by the Shulgins which mix their autobiographies with the subjective effects of new and well-studied psychadelic drugs. It lies on the cusp between top-level synthetic chemistry and guru-level self development, and is amust for anyone interested in self development or recreational drug usage. Highly recommended, but it would make more sense if one reads PIHKAL first.
OR
 

Details

This book is thinner (in every sense) than it's more famous older sibling PIHKAL, but is well worth getting if you're curious about what became of Shulgin after angering the government by publishing PIHKAL. For those with an academic interest in psychedelic drugs, it's almost a mandatory purchase, containing dozens of novel new tryptamine-based psychoactives (including several LSD derivatives), many of which are now available through the so-called research chemical trade. For better or worse, Shulgin's two books are landmark works in the developing relationship between the public, the government, and a dizzying array of new psychoactive drugs.

Alexander Sasha Theodore Shulgin (born June 17, 1925) is an American pharmacologist, chemist, artist, and drug developer. Shulgin is credited with the popularization of MDMA, commonly known as ecstasy, in the late 1970s and early 1980s, especially for psychopharmaceutical use and the treatment of depression and post-traumatic stress disorder. In subsequent years, Shulgin discovered, synthesized, and bioassayed over 230 psychoactive compounds. In 1991 and 1997, he and his wife Ann Shulgin authored the books PiHKAL and TiHKAL on the topic of psychoactive drugs. Shulgin discovered many noteworthy phenethylamines including the 2C* family of which 2C-T-2, 2C-T-7, 2C-E, 2C-I, and 2C-B are most well known. Additionally, Shulgin performed seminal work into the descriptive synthesis of compounds based on the organic compound tryptamine.

Additional Information

Custom Stock Status N/A